UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Shear‐induced unfolding activates von Willebrand factor A2 domain for proteolysis

Journal of thrombosis and haemostasis, 2009-12, Vol.7 (12), p.2096-2105

2009

Volltextzugriff (PDF)

Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami

Journal of thrombosis and haemostasis, 2016-09, Vol.14 (9), p.1725-1735

2016

Volltextzugriff (PDF)

Phenotypic and genotypic characterization of 10 Finnish patients with von Willebrand disease type 3: discovery of two main mutations

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-11, Vol.19 (6), p.e344-e348

2013

Volltextzugriff (PDF)

Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery

British journal of anaesthesia : BJA, 2011-04, Vol.106 (4), p.494-500

2011

Volltextzugriff (PDF)

Identification of a homozygous Cys410Ser mutation in the von Willebrand factor D2 domain causing type 2A(IIC) von Willebrand disease phenotype in an Iranian patient

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-07, Vol.19 (4), p.e261-e264

2013

Volltextzugriff (PDF)

The problem of novel FVIII missense mutations for haemophilia A genetic counseling

Hämostaseologie, 2009, Vol.29 (2), p.158-160

2009

Volltextzugriff (PDF)

Response to DDAVP in children with von Willebrand disease type 2

Hämostaseologie, 2009, Vol.29 (2), p.143-148

2009

Volltextzugriff (PDF)

PB0260 Immune Complex-Mediated Acquired von Willebrand Syndrome in a 5-year-old Boy after Allogeneic Hematopoietic Stem Cell Transplantation

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101395, Article 101395

2023

Volltextzugriff (PDF)

von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor

Thrombosis and haemostasis, 2014, Vol.112 (1), p.96-108

2014

Volltextzugriff (PDF)

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

Blood, 2016-04, Vol.127 (14), p.1761-1769

2016

Volltextzugriff (PDF)

Quantitative and qualitative changes of von Willebrand factor during cardiac surgery: 6AP1-7

European journal of anaesthesiology, 2007-06, Vol.24 Suppl 39 (Supplement 39), p.66-66

2007

Volltextzugriff (PDF)

Principles of care for the diagnosis and treatment of von Willebrand disease

Haematologica (Roma), 2013-05, Vol.98 (5), p.667-674

2013

Volltextzugriff (PDF)

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

Blood, 2013-03, Vol.121 (12), p.2336-2339

2013

Volltextzugriff (PDF)

Clinical efficacy of SARS‐CoV‐2 Omicron‐neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency

Journal of medical virology, 2024-06, Vol.96 (6), p.e29738-n/a

2024

Volltextzugriff (PDF)

Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease

Blood, 2001-04, Vol.97 (7), p.2059-2066

2001

Volltextzugriff (PDF)

Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization

Thrombosis and haemostasis, 2004-07, Vol.92 (1), p.36-41

2004

Volltextzugriff (PDF)

Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: Secondary analysis of the Euro-Ewing99-R1 trial

European journal of cancer (1990), 2015-11, Vol.51 (16), p.2453-2464

2015

Volltextzugriff (PDF)

Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-01, Vol.15 (1), p.267-280

2009

Volltextzugriff (PDF)

Morbidity and mortality of patients with haemophilia in Germany--update 2010/2011

Hämostaseologie, 2012, Vol.32 Suppl 1, p.S5

2012

Volltextzugriff (PDF)

Identification of a homozygous Cys410Ser mutation in the von Willebrand factor D2 domain causing type 2A(IIC) von Willebrand disease phenotype in an Iranian patient

Haemophilia : the official journal of the World Federation of Hemophilia, 2013, Vol.19 (4), p.e261-e264

2013

Volltextzugriff (PDF)

von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein

Journal of thrombosis and haemostasis, 2011-07, Vol.9, p.209-215

2011

Volltextzugriff (PDF)

Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis

Blood coagulation & fibrinolysis, 2014-04, Vol.25 (3), p.206-216

2014

Volltextzugriff (PDF)

Upshaw-Schulman syndrome-associated ADAMTS13 variants possess proteolytic activity at the surface of endothelial cells and in simulated circulation

PloS one, 2020-05, Vol.15 (5), p.e0232637-e0232637

2020

Volltextzugriff (PDF)

von Willebrand factor is dimerized by protein disulfide isomerase

Blood, 2016-03, Vol.127 (9), p.1183-1191

2016

Volltextzugriff (PDF)

1 – 25 von 454

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(426)
Mit Volltextzugriff
(369)

Publikationsform

Sprache

Englisch
(434)
Deutsch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(270)
Humans
(263)
Life Sciences & Biomedicine
(257)
Hematology
(141)
Male
(128)
Female
(125)
Biological And Medical Sciences
(100)
Medical Sciences
(88)
Child
(73)
Mutation
(67)
Von Willebrand Factor
(62)
Von Willebrand Factor - Genetics
(60)
Cardiovascular System & Cardiology
(59)
Adult
(57)
Child, Preschool
(56)
Peripheral Vascular Disease
(56)
Hematologic And Hematopoietic Diseases
(51)
Von Willebrand Factor - Metabolism
(51)
Adolescent
(50)
Infant
(48)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(56)
Journal Of Thrombosis And Haemostasis
(27)
Hämostaseologie
(24)
Thrombosis And Haemostasis
(18)
Biophysical Journal
(12)
Klinische Pädiatrie
(12)
Pediatric Blood & Cancer
(12)
Seminars In Thrombosis And Hemostasis
(12)
Neuro-Oncology
(11)
Polar Biology
(9)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Shear‐induced unfolding activates von Willebrand factor A2 domain for proteolysis

Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami

Phenotypic and genotypic characterization of 10 Finnish patients with von Willebrand disease type 3: discovery of two main mutations

Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery

Identification of a homozygous Cys410Ser mutation in the von Willebrand factor D2 domain causing type 2A(IIC) von Willebrand disease phenotype in an Iranian patient

The problem of novel FVIII missense mutations for haemophilia A genetic counseling

Response to DDAVP in children with von Willebrand disease type 2

PB0260 Immune Complex-Mediated Acquired von Willebrand Syndrome in a 5-year-old Boy after Allogeneic Hematopoietic Stem Cell Transplantation

von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

Quantitative and qualitative changes of von Willebrand factor during cardiac surgery: 6AP1-7

Principles of care for the diagnosis and treatment of von Willebrand disease

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Clinical efficacy of SARS‐CoV‐2 Omicron‐neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency

Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease

Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization

Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: Secondary analysis of the Euro-Ewing99-R1 trial

Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene

Morbidity and mortality of patients with haemophilia in Germany--update 2010/2011

Identification of a homozygous Cys410Ser mutation in the von Willebrand factor D2 domain causing type 2A(IIC) von Willebrand disease phenotype in an Iranian patient

von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein

Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis

Upshaw-Schulman syndrome-associated ADAMTS13 variants possess proteolytic activity at the surface of endothelial cells and in simulated circulation

von Willebrand factor is dimerized by protein disulfide isomerase

Suchergebnisse filtern